The expression of E-cadherin and ZO-1 was decreased in IC/BPS, but not in OAB patients, suggesting a prominent barrier function of urothelium in IC/BPS but not altered in the OAB bladders [66]. This evidence concerns the gene CDH1 and Bartsocas-Papas syndrome 1.